INTERMITTENT STRESS AUGMENTATION PACING FOR CARDIOPROTECTIVE EFFECT

• US 20090043348A1
• Filed: 10/14/2008
• Published: 02/12/2009
• Est. Priority Date: 01/06/2005
• Status: Active Grant

• Current Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Original Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Inventors: Pastore, Joseph M., Vanagt, Ward Y.R., Spinelli, Julio C., Prinzen, Frits W., Cornelussen, Richard N.
• Granted Patent: US 8,214,040 B2
• Time in Patent Office: Days
• US Class Current: 607/17
• CPC Class Codes: A61N 1/3622 comprising two or more electrodes co-operating with different heart regions

Abstract

A device and method for delivering electrical stimulation to the heart in a manner which provides a protective effect is disclosed. The protective effect is produced by configuring a cardiac pacing device to intermittently switch from a normal operating mode to a stress augmentation mode in which the spatial pattern of lo depolarization is varied to thereby subject a particular region or regions of the ventricular myocardium to increased mechanical stress.

Claims

1. A method, comprising:

implanting a device that includes a pacing channel for delivering pacing pulses to a selected myocardial site and a controller for controlling the delivery of pacing pulses in accordance with a programmed pacing mode; and

,

programming the controller to intermittently switch from a normal operating mode to a stress augmentation mode in which a particular region or regions of the myocardium are subjected to increased mechanical stress as compared with the stress experienced by those regions during the normal operating mode.

2. The method of claim 1 wherein the normal operating mode is a primary pacing mode for delivering pacing therapy and wherein stress augmentation mode causes a different depolarization pattern than the primary pacing mode.

3. The method of claim 2 wherein the stress augmentation mode excites the myocardium at a site or sites different from the primary pacing mode.

4. The method of claim 2 wherein the switch from a primary pacing mode to a stress augmentation mode involves switching form bipolar pacing to unipolar pacing or vice-versa.

5. The method of claim 2 wherein the switch from a primary pacing mode to a stress augmentation mode involves switching which electrode of a bipolar pacing lead is the cathode and which electrode is the anode.

6. The method of claim 2 wherein the implanted device that includes multiple pacing channels for delivering pacing pulses to a plurality of pacing sites, and further comprising programming the controller such that the stress augmentation mode uses at least one pacing channel not used in the primary pacing mode.

7. The method of claim 6 wherein the switch from a primary pacing mode to a stress augmentation mode involves switching from left ventricle-only pacing to right ventricular pacing or vice-versa.

8. The method of claim 6 wherein the switch from a primary pacing mode to a stress augmentation mode involves switching from biventricular pacing to single ventricular pacing or vice-versa.

9. The method of claim 1 wherein the implanted device includes an exertion level sensor and further comprising programming the controller such that the switch from a normal operating mode to a stress augmentation mode is inhibited if the measured exertion level is above a specified limit value.

10. The method of claim 1 further comprising programming the controller to detect cardiac ischemia from an electrogram morphology analysis and such that the switch from a normal operating mode to a stress augmentation mode is inhibited if cardiac ischemia is detected.

11. The method of claim 1 wherein the device is implanted into a patient who has or is likely to develop heart failure.

12. The method of claim 1 wherein the device is implanted into a patient who has or is likely to develop cardiac ischemia.

13. The method of claim 1 further comprising programming the controller to switch to the stress augmentation mode according to a defined schedule.

14. The method of claim 1 further comprising programming the controller to switch to the stress augmentation mode upon receiving a command to do so via a patient management network.

15. The method of claim 1 further comprising programming the controller to switch to the stress augmentation mode when a measured exertion level is above a specified value.

16. The method of claim 1 further comprising programming the controller to switch to the stress augmentation mode when a measured exertion level is below a specified value.

17. The method of claim 1 further comprising programming the controller to switch to the stress augmentation mode when a measured exertion level is below a specified value and a determined time of day indicates the patient is expected to be sleeping.

18. The method of claim 1 further comprising programming the controller to switch to the stress augmentation mode when a measured exertion level is above a specified value and a determined time of day indicates the patient is expected to be awake.